Tressler Nick B.
SEC insider (Form 3/4/5 filer). CIK 0001794362. Chief Financial Officer at Vistagen Therapeutics, Inc. (VTGN). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Tressler Nick B. has filed insider reports for
- Vistagen Therapeutics, Inc. (VTGN): Officer, Chief Financial Officer
Tressler Nick B.
CIK: 0001794362
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VTGN
Vistagen Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 30, 2026VTGN
Vistagen Therapeutics, Inc.
AwardDirect11.7K shares at avg. $0.19$2K - Apr 7, 2026VTGN
Vistagen Therapeutics, Inc.
AwardDirectIncentive Stock Option (right to buy)
75K shares- - Dec 1, 2025VTGN
Vistagen Therapeutics, Inc.
AwardDirectCommon Stock (Right to Buy)
150K shares-
1-3 of 3 transactions